Investors

Events

Bristol-Myers Squibb Investor Event: ASCO 2014 - Tentative
Monday, June 2, 2014 7:00 a.m. CT
Add to Calendar Add Bristol-Myers Squibb Investor Event: ASCO 2014 - Tentative to Calendar  Help
2014 Annual Meeting of Stockholders
Tuesday, May 6, 2014 10:00 a.m. ET
Download Event Supporting Material Online Proxy Materials
Add to Calendar Add 2014 Annual Meeting of Stockholders to Calendar  Help
Bristol-Myers Squibb at Cowen Health Care Conference
Tuesday, March 4, 2014 10:00 a.m. ET
Download Event Supporting Material Presentation (PDF: 2 MB)

More Events

Key Facts

Chief Executive Officer:
Lamberto Andreotti
Headquarters:
New York City
Business:
Biopharmaceuticals
Web Address:
www.bms.com
NYSE Listing:
BMY
View All Key Facts
$50.71 Stock is Down 0.24 (0.47%)
View All Stock Information

R&D Pipeline

Bristol-Myers Squibb's pipeline is one of the most innovative in the industry. Learn more about the medicines we are developing.
Learn more

View our R&D Pipeline
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

Materials on this website may contain information about the Company’s future plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents are available from the Securities and Exchange Commission, the Bristol-Myers Squibb website or from Bristol-Myers Squibb Investor Relations.

In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change, whether as a result of new information, future events or otherwise. Consequently, the company will not update the information contained on the website and investors should not rely upon the information as current or accurate after the presentation date. The website may also contain certain non-GAAP financial measures, adjusted to include certain costs, expenses, gains and losses and other specified items. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com.